Hyper-Ig E syndrome, A clinical case
Introduction. Hyper-IgE syndrome or Job's syndrome is a primary immunodeficiency condition characterized by a clinical triad: recurrent staphylococcal skin infection, recurrent pneumonias with pneumocoele formation, eczematous dermatitis, and high levels (more than 1000 IU/ml) of IgE in serum. Also, 90% of patients have eosinophilia. There are two types of hyper-IgE syndrome: Type I (autosomal dominant, with multiple organ damage, including the immune system, connective tissue, musculoskeletal, vascular systems) and type II (autosomal recessive variant of hyper-IgE syndrome with recurrent infections of the respiratory tract and lungs, severe skin viral infections (molluscum contagiosum), autoimmune diseases, oncopathology). Job's syndrome is associated with a mutation of the STAT3 gene, which is involved in signal transduction of cytokine families. For diagnosis, the level of IgE in the blood serum is examined. The basis of treatment of patients with hyper-IgE syndrome is antimicrobial therapy, topical treatment of eczematous dermatitis, surgical treatment (thoracic, orthopedic interventions, drainage of abscesses), immunobiological therapy with omalizumab. Some patients require a bone marrow transplant. Materials and methods: clinical, laboratory, instrumental. Results and discussion. We present a clinical case of a 55-year-old patient who was consulted by a dermatologist, rheumatologist, hematologist, and immunologist, and laboratory and instrumental studies were performed, which allowed us to establish a diagnosis of Job's syndrome and prescribe treatment. Conclusions: hyper-IgE syndrome is often found situationally. Patients should be examined by related specialists, taking into account possible complications. It is desirable to create a national PID database for timely assistance and the possibility of state compensation for high-cost treatment.
Key words: hyper-IgE (Job's syndrome), primary immunodeficiency, triad, complications, treatment.
Wissem Hafsi Job Syndrome / Wissem Hafsi; Siva Naga S. Yarrarapu // StatPearls Publishing, - 2022. - Access mode: https://www.ncbi.nlm.nih.gov/books/NBK525947.
Chopyak V.V. Hyper-IgE syndrome in the practice of an allergist and immunologist / V.V. Chopyak, S.O. Zubchenko, G.O. Potemkina // Asthma and allergy. – 2016. – No. 2. -. 16-20. - Access mode: http://www.ifp.kiev.ua/doc/journals/aa/16/pdf16-2/16.pdf.
Hashemi H Hyperimmunoglobulin E syndrome: Genetics, immunopathogenesis, clinical findings, and treatment modalities / H. Hashemi, M. Mohebbi, S. Mehravaran et al. // J Res Med Sci. – 2017. - Access mode: https://pubmed.ncbi.nlm.nih.gov/28567072/.
Ponsford MJ Hyper-IgE in the allergy clinic - when is it primary immunodeficiency? / Ponsford MJ, Klocperk A et al. // Allergy. – 2018. - 73(11). – Р. 2122-2136. – Access mode: https://pubmed.ncbi.nlm.nih.gov/30043993/.
Gernez Y Autosomal Dominant Hyper-IgE Syndrome in the USIDNET Registry / Gernez Y, Freeman AF, Holland SM et al. // J Allergy Clin Immunol Pract. – 2018. - 6(3). – Р. 996-1001.
Goel S. STAT3-Mediated Transcriptional Regulation of Osteopontin in STAT3 Loss-of-Function Related Hyper IgE Syndrome / Goel S, Sahu S, Minz RW et al. // Front Immunol. – 2018. – 9. – P. 1080. – Access mode: https://pubmed.ncbi.nlm.nih.gov/29868029/.
Bazregari S. Evaluation of infectious and non-infectious complications in patients with primary immunodeficiency / Bazregari S., Azizi G., Tavakol M. et al. // Cent Eur J Immunol. – 2017. - 42(4). – P. 336-341. – Access mode: https://pubmed.ncbi.nlm.nih.gov/29479289/.
Sanjuan M.A. Role of IgE in autoimmunity / Journal of Allergy and Clinical Immunology // M.A. Sanjuan, D. Sagar, R. Kolbeck. – 2016. - V. 137, I. 6. – P. 1651-1661. – Acsess mode: https://www.sciencedirect.com/science/article/abs/pii/S0091674916301907.
Chopyak V.V. Analisis of the prevalence of hyper-IgE syndrome among practically healthy young adults / V.V. Chopyak, S.O. Zubchenko, I.P. Pasichnyuk // Herald of problems of biology and medicine. – 2014. – No.3, I. 1 (110). - 380-386. - Access mode: https://vpbm.com.ua/ua/vpbm-2014-03-1/6653.
Omalizumab / Compendim/handbook of drugs - Access mode: https://compendium.com.ua/uk/akt/79/117291/omalizumabum/.
Alekseeva N.P. Clinical case of hyper-IgE syndrome / N.P. Alekseeva // International medical journal. – 2015. – V. 21, No. 4. – P. 20-23. - Access mode: http://dspace.nbuv.gov.ua/handle/123456789/113826.
Cahyanur R. Diffuse Large B-Cell Lymphoma and Job’s Syndrome: A Case Report / R. Cahyanur, S. Rahmawati // Journal of Clinical Medicine. – 2020. – 15 (2). – P. 269-271. – Acces mode: https://www.maedica.ro/articles/2020/2/2020_15(18)_No2_pg269-271.pdf.
How to Cite
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 Unported License.The names and email addresses, indicate to the user the website of the journal, will be used solely for internal technical problems of this journal; they will not be distributed and shared with third parties.